Friday, February 18, 2011 11:25:57 AM
01/06/2010 15:47:33 Bought 500 ARCI @ 2.32 -1,165.00 ---
01/11/2010 14:13:30 Sold 461 ARCI @ 2.69 1,235.05 ---
01/20/2010 09:32:55 Sold 39 ARCI @ 3.52 132.27 ---
PS did get some later but should of stayed on saddle.
08/12/2010 12:00:14 Bought 1000 ARCI @ 2.03 -2,035.00 ---
08/13/2010 09:35:26 Sold 1000 ARCI @ 2.5 2,494.95 ---
Page:
Recent JAN News
- JanOne Regains Compliance with Nasdaq's Listing Requirements • PR Newswire (US) • 03/15/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:22:34 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/09/2024 05:36:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:28:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:33:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/22/2023 09:00:42 PM
- JanOne to Present at the Dawson James 8th Annual Investment Conference • PR Newswire (US) • 09/21/2023 03:30:00 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:33:01 PM
- JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference • PR Newswire (US) • 08/31/2023 05:30:00 PM
- JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain • PR Newswire (US) • 08/29/2023 05:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2023 09:20:13 PM
- JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/25/2023 06:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 08/24/2023 08:30:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:33:11 PM
- JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/22/2023 09:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/22/2023 04:54:17 PM
- JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/18/2023 11:00:00 PM
- JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/18/2023 04:42:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/16/2023 07:55:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 08:39:17 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/07/2023 08:19:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 08:24:10 PM
- JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain • PR Newswire (US) • 06/28/2023 12:30:00 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM